Dow Down 0.92% Nasdaq Down 0.83%

Agenus Inc. (AGEN)

-NasdaqCM
3.00 0.00(0.00%) Oct 22, 4:00PM EDT
Prev Close:3.00
Open:3.02
Bid:2.80 x 5000
Ask:3.56 x 1000
1y Target Est:7.00
Beta:1.82
Next Earnings Date:N/A
Day's Range:2.95 - 3.06
52wk Range:2.27 - 5.27
Volume:315,264
Avg Vol (3m):411,628
Market Cap:188.04M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGEN 0.00%188.04M
ABPIDown 10.00%403.90K
DNDNDown 6.36%160.09M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback